Abstract
Cationic antimicrobial peptides (CAMPs) are integral compounds of the antimicrobial arsenals in virtually all kinds of organisms, with important roles in microbial ecology and higher organisms’ host defense. Many bacteria have developed countermeasures to limit the efficacy of CAMPs such as defensins, cathelicidins, kinocidins, or bacteriocins. The best-studied bacterial CAMP resistance mechanisms involve electrostatic repulsion of CAMPs by modification of cell envelope molecules, proteolytic cleavage of CAMPs, production of CAMP-trapping proteins, or extrusion of CAMPs by energy-dependent efflux pumps. The repertoire of CAMPs produced by a given host organism and the efficiency of microbial CAMP resistance mechanisms appear to be crucial in host-pathogen interactions, governing the composition of commensal microbial communities and the virulence of bacterial pathogens. However, all CAMP resistance mechanisms have limitations and bacteria have never succeeded in becoming fully insensitive to a broad range of CAMPs. CAMPs or conserved CAMP resistance factors are discussed as new mediators and targets, respectively, of novel and sustainable anti-infective strategies.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Abachin E, Poyart C, Pellegrini E, Milohanic E, Fiedler F, Berche P, Trieu-Cuot P (2002) Formation of D-alanyl-lipoteichoic acid is required for adhesion and virulence of Listeria monocytogenes. Mol Microbiol 43:1–14
Andres E, Dimarcq JL (2004) Cationic antimicrobial peptides: update of clinical development. J Intern Med 255:519–520
Bader MW, Navarre WW, Shiau W, Nikaido H, Frye JG, McClelland M, Fang FC, Miller SI (2003) Regulation of Salmonella typhimurium virulence gene expression by cationic antimicrobial peptides. Mol Microbiol 50:219–230
Bader MW, Sanowar S, Daley ME, Schneider AR, Cho U, Xu W, Klevit RE, Le Moual H, Miller SI (2005) Recognitionof antimicrobial peptides by a bacterial sensor kinase. Cell 122:461–472
Bayer AS, Prasad R, Chandra J, Koul A, Smriti M, Varma A, Skurray RA, Firth N, Brown MH, Koo S-P, Yeaman MR (2000) In vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal proteins is associated with alterations in cytoplasmic membrane fluidity. Infect Immun 68:3548–3553
Bengoechea JA, Skurnik M (2000) Temperature-regulated efflux pump/potassiumantiporter system mediates resistance to cationic antimicrobial peptides in Yersinia. Mol Microbiol 37:67–80
Bisno AL, Brito MO, Collins CM (2003) Molecular basis of group A streptococcal virulence. Lancet Infect Dis 3:191–200
Brissette CA, Simonson LG, Lukehart SA (2004) Resistance to human beta-defensins is common among oral treponemes. Oral Microbiol Immunol 19:403–407
Campos MA, Vargas MA, Regueiro V, Llompart CM, Alberti S, Bengoechea JA (2004) Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect Immun 72:7107–7114
Cao M, Helmann JD (2004) The Bacillus subtilis extracytoplasmic-function sigmaX factor regulates modification of the cell envelope and resistance to cationic antimicrobial peptides. J Bacteriol 186:1136–1146
Collins LV, Kristian SA, Weidenmaier C, Faigle M, Van Kessel KP, Van Strijp JA, Gotz F, Neumeister B, Peschel A (2002) Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice. J Infect Dis 186:214–219
Cotter PD, Guinane CM, Hill C (2002) The LisRK signal transduction system determines the sensitivity of Listeria monocytogenes to nisin and cephalosporins. Antimicrob Agents Chemother 46:2784–2790
Devaux PF, Morris R (2004) Transmembrane asymmetry and lateral domains in biological membranes. Traffic 5:241–246
Dorschner RA, Lopez-Garcia B, Peschel A, Kraus D, Morikawa K, Nizet V, Gallo RL (2006) The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB J 20:35–42
Dunman PM, Murphy E, Haney S, Palacios D, Tucker-Kellogg G, Wu S, Brown EL, Zagursky RJ, Shlaes D, Projan SJ (2001) Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci. J Bacteriol 183:7341–7353
Dürr M, Peschel A (2002) Chemokines meet defensins—the merging concepts of chemoattractants and antimicrobial peptides in host defense. Infect Immun 70:6515–6517
Edelstein PH, Hu B, Higa F, Edelstein MA (2003) lvgA, a novel Legionella pneumophila virulence factor. Infect Immun 71:2394–2403
Ernst RK, Yi EC, Guo L, Lim KB, Burns JL, Hackett M, Miller SI (1999) Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 286:1561–1565
Ernst RK, Guina T, Miller SI (2001) Salmonella typhimuriumoutermembrane remodeling: role in resistance to host innate immunity. Microbes Infect 3:1327–1334
Frick IM, Akesson P, Rasmussen M, Schmidtchen A, Bjorck L (2003) SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides. J Biol Chem 278:16561–16566
Ganz T (2003) Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3:710–720
Gao LY, Laval F, Lawson EH, Groger RK, Woodruff A, Morisaki JH, Cox JS, Daffe M, Brown EJ (2003) Requirement for kasB in Mycobacteriummycolic acid biosynthesis, cell wall impermeability and intracellular survival: implications for therapy. Mol Microbiol 49:1547–1563
García Véscovi E, Soncini FC, Groisman EA (1996) Mg2+ as an extracellular signal: environmental regulation of Salmonella virulence. Cell 84:165–174
Groisman EA (1994) How bacteria resist killing by host defense peptides. Trends Microbiol Sci 2:444–448
Groisman EA (2001) The pleiotropic two-component regulatory system PhoP-PhoQ. J Bacteriol 183:1835–1842
Gross M, Cramton S, Goetz F, Peschel A (2001) Key role of teichoic acid net charge in Staphylococcus aureus colonization of artificial surfaces. Infect Immun 69:3423–3426
Guder A, Wiedemann I, Sahl HG (2000) Post translationally modified bacteriocins—the lantibiotics. Biopolymers 55:62–73
Guina T, Yi EC, Wang H, Hackett M, Miller SI (2000) A PhoP-regulated outermembrane protease of Salmonella enterica serovar typhimurium promotes resistance to alpha-helical antimicrobial peptides. J Bacteriol 182:4077–4086
Gunn JS, Lim KB, Krueger J, Kim K, Guo L, Hackett M, Miller SI (1998) PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol Microbiol 27:1171–1182
Gunn JS, Ryan SS, Van Velkinburgh JC, Ernst RK, Miller SI (2000) Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of Salmonella enterica serovar Typhimurium. Infect Immun 68:6139–6146
Guo L, Lim KB, Poduje CM, Daniel M, Gunn JS, Hackett M, Miller SI (1998) Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell 95:189–198
Gustafson J, Strassle A, Hachler H, Kayser FH, Berger-Bachi B (1994) The femC locus of Staphylococcus aureus required for methicillin resistance includes the glutamine synthetase operon. J Bacteriol 176:1460–1467
Hancock RE, Chapple DS (1999) Peptide antibiotics. Antimicrob Agents Chemother 43:1317–1323
Hornef MW, Putsep K, Karlsson J, Refai E, Andersson M (2004) Increased diversity of intestinal antimicrobial peptides by covalent dimer formation. Nat Immunol 5:836–843
Huijbregts RP, de Kroon AI, de Kruijff B (2000) Topology and transport of membrane lipids in bacteria. Biochim Biophys Acta 1469:43–61
Islam D, Bandholtz L, Nilsson J, Wigzell H, Christensson B, Agerberth B, Gudmundsson G ( 2001) Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med 7:180–185
Jack RW, Bierbaum G, Sahl H-G (1998) Lantibiotics and related peptides. Springer, Berlin Heidelberg New York
Jerse AE, Sharma ND, Simms AN, Crow ET, Snyder LA, Shafer WM (2003) Agonococcal effluxpump systemenhances bacterial survival in a femalemousemodel of genital tract infection. Infect Immun 71:5576–5582
Jin T, Bokarewa M, Foster T, Mitchell J, Higgins J, Tarkowski A (2004) Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J Immunol 172:1169–1176
Joly S, Maze C, McCray PB Jr, Guthmiller JM (2004) Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol 42:1024–1029
Katzif S, Danavall D, Bowers S, Balthazar JT, Shafer WM (2003) The major cold shock gene, cspA, is involved in the susceptibility of Staphylococcus aureus to an antimicrobial peptide of human cathepsin G. Infect Immun 71:4304–4312
Koprivnjak T, Peschel A, Gelb MH, Liang NS, Weiss JP (2002) Role of charge properties of bacterial envelope in bactericidal action of human Group IIA phospholipase A2 against Staphylococcus aureus. J Biol Chem 277:47636–47644
Kristian SA, Durr M, Van Strijp JA, Neumeister B, Peschel A (2003a) MprF-mediated lysinylation of phospholipids in Staphylococcus aureus leads to protection against oxygen-independent neutrophil killing. Infect Immun 71:546–549
Kristian SA, Lauth X, Nizet V, Goetz F, Neumeister B, Peschel A, Landmann R (2003b) Alanylation of teichoic acids protects Staphylococcus aureus against Toll-like receptor 2-dependent host defense in a mouse tissue cage infection model. J Infect Dis 188:414–423
Kristian S, Datta V, Weidenmaier C, Kansal R, Fedtke I, Peschel A, Gallo R, Nizet V (2005) D-alanylation of teichoic acids promotes group A streptococcus antimicrobial peptide resistance, neutrophil survival, and epithelial cell invasion. J Bacteriol 187:6719–6725
Kupferwasser LI, Skurray RA, Brown MH, Firth N, Yeaman MR, Bayer AS (1999) Plasmid-mediated resistance to thrombin-induced platelet microbicidal protein in staphylococci: role of the qacA locus. Antimicrob Agents Chemother 43:2395–2399
Lay FT, Anderson MA (2005) Defensins—components of the innate immune system in plants. Curr Protein Pept Sci 6:85–101
Lehrer RI (2004) Primate defensins. Nat Rev Microbiol 2:727–738
Leippe M, Herbst R (2004) Ancient weapons for attack and defense: the pore-forming polypeptides of pathogenic enteric and free-livingamoeboid protozoa. J Eukaryot Microbiol 51:516–521
Maxwell AI, Morrison GM, Dorin JR (2003) Rapid sequence divergence in mammalian beta-defensins by adaptive evolution. Mol Immunol 40:413–421
McPhee JB, Lewenza S, Hancock RE (2003) Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol Microbiol 50:205–217
Midorikawa K, Ouhara K, Komatsuzawa H, Kawai T, Yamada S, Fujiwara T, Yamazaki K, Sayama K, Taubman MA, Kurihara H, Hashimoto K, Sugai M (2003) Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes. Infect Immun 71:3730–3739
Miller SI, Ernst RK, Bader MW (2005) LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol 3:36–46
Neuhaus FC, Baddiley J (2003) Acontinuumof anionic charge: structures and functions of D-alanyl-teichoic acids in Gram-positive bacteria. Microbiol Mol Biol Rev 67:686–723
Nguyen TX, Cole AM, Lehrer RI (2003) Evolution of primate theta-defensins: a serpentine path to a sweet tooth. Peptides 24:1647–1654
Nishimura E, Eto A, Kato M, Hashizume S, Imai S, Nisizawa T, Hanada N (2004) Oral streptococci exhibit diverse susceptibility to human beta-defensin-2: antimicrobial effects of hBD-2 on oral streptococci. Curr Microbiol 48:85–87
Nizet V (2005) Antimicrobial peptide resistance in human bacterial pathogens. In: Gallo RL (ed) Antimicrobial peptides in human health and disease. Horizon Bioscience, Norfolk, UK, pp 277–304
Nizet V, Gallo RL (2003) Cathelicidins and innate defense against invasive bacterial infection. Scand J Infect Dis 35:670–676
Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, Dorschner RA, Pestonjamasp V, Piraino J, Huttner K, Gallo RL (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414:454–457
Nummila K, Kilpeläinen I, Zähringer U, Vaara M, Helander IM (1995) Lipopolysac-charides of polymyxin B-resistant mutants of Escherichia coli are extensively sub-stituted by 2-aminoethyl pyrophosphate and contain aminoarabinose in lipid A. Mol Microbiol 16:271–278
Oku Y, Kurokawa K, Ichihashi N, Sekimizu K (2004) Characterization of the Staphylococcus aureus mprF gene, involved in lysinylation of phosphatidylglycerol. Microbiology 150:45–51
Otto M (2005) Bacterial evasion of antimicrobial peptides by biofilm formation. In: Shafer WM (ed) Antimicrobial peptides and human disease. Curr Top Microbiol Immunol (in press)
Pag U, Sahl HG (2002) Multiple activities in lantibiotics—models for the design of novel antibiotics? Curr Pharm Des 8:815–833
Patil A, Hughes AL, Zhang G (2004) Rapid evolution and diversification of mammalian alpha-defensins as revealed by comparative analysis of rodent and primate genes. Physiol Genomics 20:1–11
Peacock SJ, de Silva I, Lowy FD (2001) What determines nasal carriage of Staphylococcus aureus? Trends Microbiol 9:605–610
Perego M, Glaser P, Minutello A, Strauch MA, Leopold K, Fischer W (1995) Incorporation of D-alanine into lipoteichoic acid and wall teichoic acid in Bacillus subtilis. J Biol Chem 270:15598–15606
Peschel A (2002) How do bacteria resist human antimicrobial peptides? Trends Microbiol 10:179–186
Peschel A, Götz F (1996) Analysis of the Staphylococcus epidermidis genes epiF, E, and G involved in epidermin immunity. J Bacteriol 178:531–536
Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, Götz F (1999) Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins and other antimicrobial peptides. J Biol Chem 274:8405–8410
Peschel A, Vuong C, Otto M, Götz F (2000) The D-alanine residues of Staphylococcus aureus teichoic acids alter the susceptibility to vancomycin and the activity of autolysins. Antimicrob Agents Chemother 44:2845–2847
Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson G, Kalbacher H, Nieuwenhuizen WF, Jung G, Tarkowski A, van Kessel KPM, van Strijp JAG (2001) Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with L-lysine. J Exp Med 193:1067–1076
Poyart C, Pellegrini E, Marceau M, Baptista M, Jaubert F, Lamy MC, Trieu-Cuot P (2003) Attenuated virulence of Streptococcus agalactiae deficient in D-alanyl-lipoteichoic acid is due to an increased susceptibility to defensins and phagocytic cells. Mol Microbiol 49:1615–1625
Proctor RA, Kahl B, von Eiff C, Vaudaux PE, Lew DP, Peters G (1998) Staphylococcal small colony variants have novel mechanisms for antibiotic resistance. Clin Infect Dis 27[Suppl 1]:68–74
Ratledge C, Wilkinson SG (1988) Microbial lipids. Academic Press, London
Riley MA, Wertz JE (2002) Bacteriocins: evolution, ecology, and application. Annu Rev Microbiol 56:117–137
Sahl HG, Pag U, Bonness S, Wagner S, Antcheva N, Tossi A (2004) Mammalian defensins: structures andmechanism of antibiotic activity. J Leukoc Biol 77:466–475
Sahly H, Schubert S, Harder J, Rautenberg P, Ullmann U, Schroder J, Podschun R (2003) Burkholderia is highly resistant to human Beta-defensin 3. Antimicrob Agents Chemother 47:1739–1741
Schmidtchen A, Frick IM, Andersson E, Tapper H, Bjorck L (2002) Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol 46:157–168
Shafer WM, Qu X-D, Waring AJ, Lehrer RI (1998) Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc Natl Acad Sci U S A 95:1829–1833
Shelburne CE, Coulter WA, Olguin D, Lantz MS, Lopatin DE (2005) Induction of β-defensin resistance in the oral anaerobe Porphyromonas gingivalis. Antimicrob Agents Chemother 49:183–187
Sieprawska-Lupa M, Mydel P, Krawczyk K, Wojcik K, Puklo M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J (2004) Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother 48:4673–4679
Staubitz P, Peschel A (2002) MprF-mediated lysinylation of phospholipids in Bacillus subtilis—protection against bacteriocins in terrestrial environments? Microbiology 148:3331–3332
Staubitz P, Neumann H, Schneider T, Wiedemann I, Peschel A (2004) MprF-mediated biosynthesis of lysylphosphatidylglycerol, an important determinant in staphylococcal defensin resistance. FEMS Microbiol Lett 231:67–71
Steenbergen JN, Alder J, Thorne GM, Tally FP (2005) Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. J Antimicrob Chemother 53:283–288
Stumpe S, Schmid R, Stephens DL, Georgiou G, Bakker EP (1998) Identification of OmpT as the protease that hydrolyzes the antimicrobial peptide protamine before it enters growing cells of Escherichia coli. J Bacteriol 180:4002–4006
Van Veen HW, Konings WN(1997) Drug efflux proteins inmultidrug resistant bacteria. Biol Chem 378:769–777
Von Eiff C, Becker K, Machka K, Stammer H, Peters G (2001)Nasal carriage as a source of Staphylococcus aureus bacteremia. Study group. N Eng J Med 344:11–16
Vuong C, Voyich JM, Fischer ER, Braughton KR, Whitney AR, DeLeo FR, Otto M (2004) Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol 6:269–275
Wecke J, Madela K, Fischer W (1997) The absence of D-alanine from lipoteichoic acid and wall teichoic acid alters surface charge, enhances autolysis and increases susceptibility to methicillin in Bacillus subtilis. Microbiology 143:2953–2960
Weidenmaier C, Kristian SA, Peschel A (2003) Bacterial resistance to antimicrobial host defenses—an emerging target for novel antiinfective strategies? Curr Drug Targets 4:643–649
Weidenmaier C, Kokai-Kun JF, Kristian SA, Chanturyia T, Kalbacher H, Gross M, Nicholson G, Neumeister B, Mond JJ, Peschel A (2004) Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat Med 10:243–245
Weidenmaier C, Peschel A, Kempf VA, Lucindo N, Yeaman MR, Bayer AS (2005) DltABCD-and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model. Infect Immun 73:8033–8038
Wertheim HF, Vos MC, Ott A, van Belkum A, Voss A, Kluytmans JA, van Keulen PH, Vandenbroucke-Grauls CM, Meester MH, Verbrugh HA (2004) Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus noncarriers. Lancet 364:703–705
Wosten MM, Kox LF, Chamnongpol S, Soncini FC, Groisman EA (2000) A signal transduction system that responds to extracellular iron. Cell 103:113–125
Yang D, Chen Q, Hoover DM, Staley P, Tucker KD, Lubkowski J, Oppenheim JJ (2003) Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol 74:448–455
Yeaman MR, Bayer AS, Koo S-P, Foss W, Sullam PM (1998) Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action. J Clin Invest 101:178–187
Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415:389–395
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kraus, D., Peschel, A. (2006). Molecular Mechanisms of Bacterial Resistance to Antimicrobial Peptides. In: Shafer, W.M. (eds) Antimicrobial Peptides and Human Disease. Current Topics in Microbiology and Immunology, vol 306. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-29916-5_9
Download citation
DOI: https://doi.org/10.1007/3-540-29916-5_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-29915-8
Online ISBN: 978-3-540-29916-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)